Einfach Bitcoin kaufen: Mit dem Code "FINANZEN" sparen Sie 21% der Gebühren für 6 Monate bei Coinfinity. Jetzt loslegen -w-
23.10.2019 22:59:23

Edwards Lifesciences Corp. Reports Advance In Q3 Earnings

(RTTNews) - Edwards Lifesciences Corp. (EW) reported earnings for its third quarter that advanced from last year.

The company's earnings totaled $274.7 million, or $1.30 per share. This compares with $225.9 million, or $1.06 per share, in last year's third quarter.

Analysts had expected the company to earn $1.22 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 19.8% to $1.09 billion from $0.91 billion last year.

Edwards Lifesciences Corp. earnings at a glance:

-Earnings (Q3): $274.7 Mln. vs. $225.9 Mln. last year. -EPS (Q3): $1.30 vs. $1.06 last year. -Analysts Estimate: $1.22 -Revenue (Q3): $1.09 Bln vs. $0.91 Bln last year.

-Guidance: Full year EPS guidance: $5.50 - $5.65 Full year revenue guidance: $4.0 - $4.3 Bln

Analysen zu Edwards Lifesciences Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Edwards Lifesciences Corp. 66,24 -3,80% Edwards Lifesciences Corp.